Wednesday, 15 Aug 2018

You are here

RheumNow Week in Review – 22 April 2016

Highlights from this week on RheumNow.com

  1. Systematic review by Felson et al shows that MTX use in current RA clinical trials is suboptimal, most using 15mg, the highest dose was 20mg/wk and only one trial with parenteral MTX.  https://t.co/1DYHxLK2DJ
  2. There's a despirate need for effective DMARD or biologic therapy for patients with with erosive osteoarthritis! GSK announced the launch of its Phase 2 trial of GM-CSF MAb in patients with inflammatory hand OA. https://t.co/cXNdTDufR7
  3. Celltrion chief executive said that Inflectra is expected to be priced ~20-30% lower than Remicade when released in the US. https://t.co/ceCHuYubzK
  4. Perioperative MTX use does not cause increased postoperative infectious complications or sepsis in IBD patients having abdominal surgery. https://t.co/ApgCyEhpeG
  5. A New Look at Old Pictures.  Dr. David Pisetsky blogs on the appropriate or misleading use of picture to educate. 
  6. Do's and Don'ts of Vaccination: a (Very) Brief Guide for Rheumatologists by Dr. Kevin Winthrop.  
  7. Vaccine Success is Limited in Rheumatoid Arthritis.  
  8. α Defensin Control of Inflammation.  The protective effects of defensins and their therapeutic potential is proposed.  
  9. BeST Trial and 10-Year Outcomes of Four Treatment Strategies
  10. Osteoporotic Fractures at Higher Risk for Subsequent Fractures  

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on RheumNow.com. Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.

The RheumNow Week in Review – Lupus in the News (7.27.18)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week.